Dr. Lauren B. Elman, MD

Dr. Elman practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Elman's NPI, 1942231766, was assigned on July 6, 2006. Dr. Elman graduated from Weill Cornell Medicine in 1998. Dr. Elman holds Pennsylvania license MD072143L.

Dr. Elman's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.

Dr. Elman's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Elman is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Elman to 4 more hospitals, 1 home health agency, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elman practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Elman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Elman is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Elman is licensed in Pennsylvania.

Dmand AI lists fibromyalgia and chronic pain, lower back pain, mobility impairment, muscle disease, neck pain and spine problems, neuropathy and thoracic spine disorders among the conditions Dr. Elman treats.

CMS data shows 441 Medicare services from Dr. Elman across 5 procedure codes in 2024, for 191 Medicare patients. Medicare paid $26,406 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Elman in 2024. The largest group is 65 to 74, with 83 patients. 64% of them have high cholesterol, and 55% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elman's median patient age at 56, with 45% women.

In 2024, Dr. Elman wrote 819 Medicare Part D claims for 129 patients. 73% of them were for generic drugs. CMS names the drug for 637 of them, across 29 drugs with 11 or more claims each, at $3,952,528 in total drug cost. In 2023, CMS named 477 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Elman for performance year 2024, reported as part of a group. Dr. Elman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elman as offering telehealth.

Dmand AI links 150 papers to Dr. Elman, published from 2006 to 2025. 2018 was the busiest year, with 10. The most frequent topics are Amyotrophic Lateral Sclerosis, DNA-Binding Proteins and Brain. Dr. Elman has published most often in Acta Neuropathol. Dr. Elman's most frequent co-authors are Leo Francis McCluskey, MD, Virginia L. Lee, MD and Colin C. Quinn, MD.

Dmand AI links Dr. Elman to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Muscular Dystrophies, Amyotrophic Lateral Sclerosis and Muscular Dystrophies, Limb-Girdle.

CMS Open Payments shows 114 general payments to Dr. Elman from 13 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 90% of the total. Biogen, Inc. paid the most, $66,675.

Dmand AI lists 3 awards for Dr. Elman, most recently Philadelphia Magazine in 2014.

Dr. Elman graduated from Weill Cornell Medicine in 1998.

Dr. Elman is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.